SCHEMBL6313605

SCHEMBL6313605

CCCCc1c(C)c(C#N)c2nc3cc(Cl)c(Cl)cn3c2c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 5/20 0.40
HPGD P15428 4/20 0.40
MAPT P10636 4/20 0.40
HTT P42858 3/20 0.40
KMT2A Q03164 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 3/20 0.33
LMNA P02545 3/20 0.33
GAA P10253 2/20 0.33
APAF1 O14727 2/20 0.33
NOD2 Q9HC29 1/20 0.33
MEN1 O00255 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
SAE1 Q9UBE0 2/20 0.32
UBA2 Q9UBT2 2/20 0.32
BCAT2 O15382 2/20 0.32
BCAT1 P54687 1/20 0.32
SLC2A1 P11166 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6311045 0.90 KMT2A (0.43) NPSR1HPGDMAPTHTTKMT2A
SCHEMBL6312086 0.80 MAPT (0.47) NPSR1HPGDMAPTHTTKMT2A
SCHEMBL6312327 0.77 SMN1; SMN2 (0.39) NPSR1HPGDMAPTHTTKMT2A
SCHEMBL6319304 0.76 SMN1; SMN2 (0.43) NPSR1HPGDMAPTHTTKMT2A
SCHEMBL6311562 0.76 HPGD (0.43) NPSR1HPGDMAPTHTTKMT2A
SCHEMBL6310742 0.76 HPGD (0.43) NPSR1HPGDMAPTHTTKMT2A
SCHEMBL6310816 0.75 HPGD (0.46) NPSR1HPGDMAPTHTTKMT2A
SCHEMBL6310328 0.69 NPSR1 (0.44) NPSR1HPGDMAPTHTTKMT2A
SCHEMBL6310471 0.68 HSD17B10 (0.39) NPSR1HPGDMAPTHTTKMT2A
SCHEMBL6311004 0.64 ENPP2 (0.43) NPSR1HPGDMAPTSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 NPSR1 1531/4885HPGD 2061/4885MAPT 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.